--- title: "DNA Tests And Estate Planning: How 23andMe Resulted In A $28 Million DNA Surprise." type: "News" locale: "en" url: "https://longbridge.com/en/news/268654936.md" description: "Consumer DNA tests, like those from 23andMe, are reshaping estate planning by revealing previously unknown heirs, leading to legal challenges in estate distribution. Cases in the U.S. and Australia highlight how DNA evidence can alter inheritance rights, even reopening closed estates. Estate planners now recommend updating plans to account for potential DNA discoveries, ensuring clear beneficiary designations. As DNA testing becomes more accessible, it is crucial to integrate these considerations into estate planning to prevent legal disputes and ensure intended legacy distribution." datetime: "2025-12-04T18:41:36.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/268654936.md) - [en](https://longbridge.com/en/news/268654936.md) - [zh-HK](https://longbridge.com/zh-HK/news/268654936.md) --- # DNA Tests And Estate Planning: How 23andMe Resulted In A $28 Million DNA Surprise. Sunnyvale California, United States - September 24, 2021: Headquarters of 23andMe, a personal genomics and biotechnology company headquartered in Mountain View, California that provides rapid genetic testing. getty Imagine opening a birthday gift DNA kit and discovering you're entitled to millions you never knew existed. For Carmen Thomas and hundreds of Americans like her, this isn't fantasy—it's reality. Consumer DNA tests have evolved from novelty gifts into powerful legal tools that are dismantling decades-old estate plans and forcing courts to redefine "family." For estate planners and families with significant assets, the message is clear: traditional estate planning no longer accounts for genetic testing realities. Direct-to-consumer genetic testing through 23andMe, Ancestry and similar services has made it remarkably easy to identify biological parents, half-siblings and extended relatives who were previously unknown—or intentionally concealed. These discoveries frequently collide with estates where wealth has already been distributed, creating conflicts between biology, family narratives and legal intent. The Massachusetts Medical Malpractice Case: Carmen Thomas used a consumer DNA test to discover two half-sisters, then filed suit seeking a portion of roughly $28 million tied to their late father's medical malpractice award. Her case is emerging as a touchstone for how U.S. judges weigh late-discovered heirs against existing estate structures. The Colorado Cabin Dispute: A man excluded from his father's estate established biological paternity through DNA evidence and secured his rightful share—including a valuable family cabin—under state intestacy law. MORE FOR YOU The Australian Estate Reopening: In New South Wales, a man used DNA evidence to prove biological paternity to a deceased testator whose AU$1.5 million estate had already been distributed. The court accepted the genetic proof, reopened the finished estate, and awarded him an equal share. The lesson: Once paternity is legally proven, many states treat a previously unacknowledged child identically to any other child for inheritance purposes when there's no valid will stating otherwise—even reopening closed estates. If someone dies without a will or trust, a late-discovered child who can prove paternity through DNA testing may step into the statutory line of succession—regardless of whether the decedent knew of that child's existence. A DNA match creates a powerful equitable narrative but doesn't guarantee inheritance rights if a valid will or trust clearly favors other individuals. Courts typically prioritize documented intent over biology when governing documents are explicit. Courts usually require testing from accredited laboratories with chain-of-custody documentation and expert testimony before accepting paternity in probate proceedings. A 23andMe report alone won't win—or defeat—a claim. Statutes increasingly address children conceived with stored gametes or embryos, often requiring written consent and strict timelines for inheritance rights to vest. Consumer DNA makes these relationships easier to identify but doesn't replace statutory requirements. Identify beneficiaries individually rather than relying solely on broad class terms like "children," "issue," or "descendants." Clear naming reduces arguments that a surprise heir was "meant" to be included. When class terms are necessary, add explicit definitions stating whether they include: Some estate planners now recommend language clarifying that only specifically named individuals—or those known and acknowledged during the client's lifetime—are intended beneficiaries, even if additional biological relatives are later identified. Regular reviews should explicitly include material DNA discoveries as a reason to revisit your plan, alongside traditional triggers like marriage, divorce, birth of children, or major health events. Retirement accounts, life insurance, and transfer-on-death registrations pass outside your will but can still be challenged by new heirs. Keep these designations consistent with your overall plan. Family meetings and transparent communication significantly lower the emotional temperature when surprises occur—and beneficiaries are far less likely to file lawsuits when they don't feel blindsided. Estate planning in 2025 means combining traditional tools with contemporary awareness: The genie is out of the bottle. DNA testing is becoming cheaper, more accurate, and more ubiquitous every year. The families that will weather this shift best are those who plan proactively. By acknowledging that biological relationships can now be proven with near-certainty, and by drafting estate documents that account for this reality, you can ensure your legacy passes according to your wishes, not a laboratory's findings. If your estate plan was created before the DNA testing era—or hasn't been updated to account for these new realities—now is the time to revisit it with qualified legal counsel. Because in 2025, a $99 DNA kit can rewrite a million-dollar estate plan. Can a DNA test override a will? DNA establishes biological relationships, but a valid will expressing clear intent typically controls distribution. However, with no will (intestacy), DNA-proven heirs have strong statutory rights in most states. How accurate is consumer DNA testing for legal purposes? Consumer tests provide strong leads, but courts usually require confirmation from accredited forensic laboratories with proper chain-of-custody documentation and expert testimony. Can I explicitly exclude unknown biological children in my will? In many jurisdictions, yes—but the language must be carefully crafted with local law in mind. Consult an experienced estate planning attorney to ensure such provisions will be enforceable. What happens if a DNA heir appears after the estate is closed? Depending on jurisdiction, courts may reopen estates. Time limits and procedural requirements vary significantly by state and country. ### Related Stocks - [ME.US](https://longbridge.com/en/quote/ME.US.md) ## Related News & Research - [Why Wells Fargo Thinks Intel’s AI Business Is Getting Even Stronger](https://longbridge.com/en/news/294385038.md) - [Star AI investor Leopold Aschenbrenner is unwinding trades after steep losses, sources say](https://longbridge.com/en/news/294374335.md) - [Virtuix Poised for Growth After Meta Launch: Omni One for Quest Drives Consumer and Commercial Demand](https://longbridge.com/en/news/293934733.md) - [Congressman Makes First Stock Trade in Office: Here’s The Magnificent Seven Name He Sold](https://longbridge.com/en/news/294289021.md) - [onsemi $ON Shares Bought by OMERS ADMINISTRATION Corp](https://longbridge.com/en/news/294333221.md)